Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
GARP vs XLV: how they differ
GARP and XLV hold 5% of their weight in the same names, and GARP returned more over the year.
iShares MSCI USA Quality GARP ETF and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, GARP and XLV hold 5% of their money in the same securities at the same weight.
| Holding | GARP | XLV |
|---|---|---|
| ELI LILLY & COMPANY | 3.73% | 16.56% |
| IDEXX LABORATORIES INC | 0.38% | 0.72% |
| MCKESSON CORP | 0.24% | 1.59% |
| RESMED INC | 0.22% | 0.49% |
| DEXCOM INC | 0.20% | 0.45% |
| BOSTON SCIENTIFIC CORP | 0.17% | 1.11% |
| CENTENE CORP | 0.08% | 0.53% |
| INCYTE CORP | 0.05% | 0.33% |
| INSULET CORP | 0.03% | 0.18% |
| Only in GARP | Only in XLV |
|---|---|
| KLA CORP 6.46% | Johnson & Johnson 10.67% |
| MICRON TECHNOLOGY INC 6.07% | AbbVie Inc 7.76% |
| APPLE INC 4.44% | UnitedHealth Group Inc 6.59% |
| NVIDIA CORP 4.16% | Merck & Co Inc 5.54% |
| MICROSOFT CORP 4.10% | Amgen Inc 3.41% |
| BROADCOM INC 3.96% | Thermo Fisher Scientific Inc 3.25% |
| LAM RESEARCH CORP 3.79% | Abbott Laboratories 2.76% |
| VISA INC 3.73% | Gilead Sciences Inc 2.74% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| GARP iShares MSCI USA Quality GARP ETF | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | State Street |
| What it is | MSCI USA Quality GARP | Health care |
| Total return, 1 year | +29.5% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +12.0 pts | +2.9 pts |
| Expense ratio | 0.15% | 0.08% |
| Already in the S&P 500 | 94.4% | 100.0% |
| Holdings | 131 | 59 |
GARP in plain words
GARP is an index equity fund tracking the MSCI USA Quality GARP. Over the year to Sep 11, 2026 it returned +29.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.15% a year. By its holdings filed for Jun 30, 2026, 94% of the fund by weight is stocks the S&P 500 also holds, across 131 positions, with the top ten at 43.8%.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, GARP or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, GARP returned +29.5% and XLV returned +20.4%, so GARP returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, GARP or XLV?
- GARP charges 0.15% a year and XLV charges 0.08%, so XLV is cheaper. Fees come from each fund's prospectus.
- How much do GARP and XLV overlap with the S&P 500?
- By their latest filed holdings, 94% of GARP and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 5% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, GARP against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/GARP-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources